Evaluation of tempol radioprotection in a murine tumor model

Free Radical Biology and Medicine

Volumn 22, Issue 7, 1997, Pages 1211-1216

  Hahn, Stephen M ^a,b   Sullivan, Francis J ^a   DeLuca, Anne Marie ^a   Krishna, C Murali ^a   Wersto, Nancy ^a   Venzon, David ^a   Russo, Angelo ^a   Mitchell, James B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bioreduction; Free radicals; Nitroxides; Radioprotection; Tumor control; Tumor regrowth

Indexed keywords

FREE RADICAL; NITROXIDE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DEPRESSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PROTECTION; RADIOSENSITIVITY; TUMOR CELL; TUMOR GROWTH;

ANIMALS; BONE MARROW; CELL DIVISION; CYCLIC N-OXIDES; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RADIATION TOLERANCE; RADIATION-PROTECTIVE AGENTS; SPIN LABELS;

ANIMALIA; MURINAE;

EID: 0030970081     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00556-4     Document Type: Article

References (30)

1. McConnell H. M. Molecular motion in biological membranes. Berliner L. J. Spin labelling: Theory and applications. 1976;525-560 C.C. Thomas Publ, Springfield.
2. Bennett H. F., Swartz H. M., Brown R. D. III, Koenig S. H. Modification of relaxation of lipid protons by molecular oxygen and nitroxides. Invest. Radiol. 22:1987;502-507.
3. Swartz H. M. Interactions between cells and nitroxides and their implications for their uses as biophysical probes and as metabolically responsive contrast agents for in vivo NMR. Bull. Magn. Res. 8:1983;172-175.
4. Gallez G., Demeure R., Debuyst R., Leonard D., Dejehet F., Dumont P. Evaluation of Nonionic nitroxyl lipids as potential organ-specific contrast agents for magnetic resonance imaging. Magn. Reson. Med. 10:1992;445-455.
5. Mitchell J. B., Samuni A., Krishna M. C., DeGraff W. G., Ahn M. S., Samuni U., Russo A. Biologically active metal-independent superoxide dismutase mimics. Biochemistry. 29:1990;2802-2807.
6. Samuni A., Krishna C. M., Mitchell J. B., Collins C. R., Russo A. Superoxide reaction with nitroxides. Free Radic. Res. Commun. 9:1990;241-249.
7. Samuni A., Mitchell J. B., DeGraff W., Krishna C. M., Samuni U., Russo A. Nitroxide SOD-mimics: Modes of action. Free Radic. Res. Commun. 12-13:1991;187-194.
8. Samuni A., Winkelsberg D., Pinson A., Hahn S. M., Mitchell J. B., Russo A. Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage. J. Clin. Invest. 87:1991;1526-1530.
9. Mitchell J. B., DeGraff W., Kaufman D., Krishna M. C., Samuni A., Finkelstein E., Ahn M. S., Hahn S. M., Gamson J., Russo A. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, Tempol. Arch. Biochem. Biophys. 289:1991;62-70.
10. Hahn S. M., Wilson L., Krishna C. M., Liebmann J., DeGraff W., Gamson J., Samuni A., Venzon D., Mitchell J. B. Identification of nitroxide radioprotectors. Radiat. Res. 132:1992;87-93.
11. Hahn S. M., Tochner Z., Krishna C. M., Glass J., Wilson L., Samuni A., Sprague M., Venzon D., Glatstein E., Mitchell J. B., Russo A. Tempol, a stable free radical, is a novel murine radiation protector. Cancer Res. 52:1992;1750-1753.
12. Yuhas J. M., Storer J. B. The effect of age on two modes of radiation death and on hematopoietic cell survival in the mouse. Radiat. Res. 32:1969;596-605.
13. Goffman T., Cuscela D., Glass J., Hahn S., Krishna C. M., Lupton G., Mitchell J. B. Topical application of nitroxide protects radiation induced alopecia in guinea pigs. Int. J. Radiat. Oncol. Biol. Phys. 22:1992;803-806.
14. Emmerson P. T., Howard-Flanders P. Preferential sensitization of anoxic bacteria to X-rays by organic nitroxide-free radicals. Radiat. Res. 23:1965;54-62.
15. Pettersen E. O., Oftebro R., Brustad T. X-ray inactivation of human cells in tissue culture under aerobic and extremely hypoxic conditions in the presence and absence of TMPN. Int. J. Radiat. Biol. 24:1973;285-296.
16. Couet W. R., Brasch R. C., Sosnovsky G., Tozer T. N. Factors affecting nitroxide reduction in ascorbate solution and tissue homogenates. Magn. Reson. Imaging. 3:1985;83-88.
17. Swartz H. M. Principles of the metabolism of nitroxides and their implications for spin trapping. Free Radic. Res. Commun. 9:1990;399-405.
18. Brown J. M., Hall E. J., Hirst D. G., Kinsella T. J., Kligerman M. M., Mitchell J. B., Travis E. J., Valeriote F. Chemical modification of radiation and chemotherapy. Am. J. Clin. Oncol. 11:1988;288-303.
19. Kennedy K. A., Teicher B. A., Rockwell S., Sartorelli A. C. The hypoxic tumor cell: A target for selective cancer chemotherapy. Biochem. Pharmacol. 29:1980;1-8.
20. Teicher B. A., Lazo J. S., Sartorelli A. C. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res. 41:1981;73-81.
21. Cameron J. R., Suntharalingam N., Kenney G. N. Thermoluminescent Dosimetry. 1968;University of Wisconsin Press, Madison.
22. Russo A., Tochner Z., Phillips T., Carmichael J., DeGraff W., Friedman N., Fisher J., Mitchell J. B. In vivo modulation of glutathione by buthionine sulfoximine: Effect on marrow response to melphalan. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;1187-1189.
23. Mood A. M., Graybill F. A., Boes D. C. Introduction to the theory of statistics. 1974;McGraw-Hill, New York.
24. Yuhas J. M., Storer V. B. Differential chemoprotection of normal and malignant tissues. J. Natl. Cancer Inst. 42:1969;331-335.
25. Yuhas J. M. Active vs. passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino) ethylphosphorothioic acid. Cancer Res. 40:1980;1519-1524.
26. 35S-labelled WR-2721 in normal and malignant tissues of the mouse. Radiat. Res. 68:1976;284-291.
27. Washburn L. C., Carlton J. E., Hayes R. L. Distribution of WR-2721 in normal and malignant tissues of mice and rats bearing solid tumors: Dependence on tumor type, drug dose and species. Radiat. Res. 59:1974;475-483.
28. Cairnie A. B. Adverse effects of radioprotector WR2721. Radiat. Res. 94:1983;221-226.
29. Twentyman P. R., Brown J. M., Gray J. W., Franko A. J., Scoles M. A., Kallman R. F. A new mouse tumor model system (RIF-1) for comparison of end-point studies. J. Natl. Cancer Inst. 64:1980;595-604.
30. Brown J. M., Twentyman P. R., Zamvil S. S. Response of the RIF-1 tumor in vitro and in C3H/Km mice to x-radiation (cell survival, regrowth delay, and tumor control), chemotherapeutic agents, and activated macrophages. J. Natl. Cancer Inst. 64:1980;605-611.